Robert H. Christenson, Ph.D., DABCC, FACB
Dr. Christenson is Professor of Pathology and Professor of Medical and Research Technology at the University of Maryland School of Medicine in Baltimore Maryland . Clinically Dr. Christenson is Director of the Clinical Chemistry, Toxicology, and Rapid Response Laboratories at the University of Maryland Medical Center, where he is also Director of Point of Care Services. Dr. Christenson graduated from the University of Massachusetts and received Ph.D. in Analytical Chemistry from Florida State University . He completed post-doctoral training in clinical chemistry and laboratory medicine at the University of North Carolina in Chapel Hill . Dr. Christenson subsequently joined the faculty of Duke University until 1991 when he joined the faculty at Maryland . Dr. Christenson was certified as a Diplomate of the American Board of Clinical Chemistry in 1984 and is a Fellow of the National Academy of Clinical Biochemists.
Teaching clinical laboratory medicine to undergraduates, graduate students, medical students, residents and postdoctoral fellows has remained a primary activity for Dr. Christenson. He has directed the ComACC accredited postdoctoral training program in Clinical Chemistry for the past 15 years. Dr. Christenson holds three patents and has published over 150 peer-reviewed manuscripts, over 160 abstracts, 2 books, and 45 book chapters and monographs. He has an active research program in the area of cardiac biomarkers. Dr. Christenson is an Associate Editor for the periodical Clinical Biochemistry and is currently a member of the Board of Editors for the journals, Clinical Chemistry , and the Journal of Clinical and Laboratory Analysis . Dr. Christenson is a representative on the NIH's National Heart Attack Alert Program and is currently a member of the HHS's Medicare Coverage Advisory Committee. He chairs the committee for the National Academy of Clinical Biochemistry's (NACB) Laboratory Medicine Practice Guidelines for Cardiac Biomarkers of Acute Coronary Syndromes and Heart Failure and is vice chair of the NACB's practice guidelines in the area of emerging markers of long term risk assessment for coronary artery disease. Dr. Christenson was awarded TransAtlantic Lectureship by the Academy of Clinical Biochemists in the UK . He received the 2005 Award for Outstanding Contributions in Education by the American Association for Clinical Chemistry and was awarded the 2005 Spinoza Visiting Professorship by the University of Amsterdam , Amsterdam , The Netherlands.